Arteriosclerosis and Thrombosis: A Journal of Vascular Biology

Show Articles
Journal Properties
  • Continued as
    Arteriosclerosis, Arteriosclerosis, Thrombosis, and Vascular Biology
  • Language
    English
  • Number of Articles
    850
  • Abbreviation
    Arterioscler Thromb
  • ISSN
    1049-8834
  • Main Publisher
    American Heart Association
  • Publisher
    Ovid Technologies (Wolters Kluwer Health)
  • Indian UGC
  • Indian UGC Name
  • DOAJ (latest)
Description
Arteriosclerosis and Thrombosis: A Journal of Vascular Biology provides cutting-edge research on the pathogenesis, prevention, and treatment of vascular diseases. With a focus on molecular, cellular, and translational investigations, it is a premier resource for scientists and clinicians seeking to advance their understanding of cardiovascular health. This journal covers a wide range of topics, including the mechanisms underlying arteriosclerosis, thrombosis, angiogenesis, and vascular inflammation. It features original research articles, reviews, and editorials that explore the genetic, environmental, and lifestyle factors influencing vascular biology. Additionally, it provides insights into novel diagnostic and therapeutic strategies for preventing and treating vascular diseases, including atherosclerosis. Indexed in major databases, it serves as a crucial resource for researchers in cardiology, vascular biology, and related fields. It bridges the gap between basic science and clinical application, promoting the translation of groundbreaking discoveries into improved patient care. Authors are encouraged to submit manuscripts that contribute to the advancement of vascular biology and the fight against cardiovascular disease.